GGrantIndex
← Leaderboards

Sara S. Strom

University Of Texas Md Anderson Can Ctr

$4,426,461
Attributed
$4,426,461
Total exposure
7
Grants
2
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $358K · FY200611
$500K$375K$250K$125K$0
'06
'07
'08
'09
'10
'11

Funding mix

By agency

NIH$4,426,461 · 7

By mechanism

R01$2,112,196 · 1
P30$1,649,133 · 1
R03$373,325 · 3
P50$291,807 · 1
U54$0 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Texas Md Anderson Can Ctr

Same institution · by research overlap

Others in their field

Top investigators on “Clinical Research

Research focus

Clinical ResearchHuman SubjectNeoplasm /Cancer EpidemiologyRacial /Ethnic DifferenceProstate NeoplasmsMaleGene Environment InteractionDisease /Disorder EtiologyDietCancer RiskAfrican AmericanVitamin D ReceptorsMexican AmericansNutrition Related TagAndrogen ReceptorGene InteractionSocioeconomicsGenetic MarkersMethodologyEnvironmentEnvironmental ExposureHealth SciencesArchivesEnvironmental Health

Grant awards (21)

Facility Core A: Integrative Health Sciences$339,671
P30 · FY2011 · ES · contact PI
Facility Core A: Integrative Health Sciences$346,391
P30 · FY2010 · ES · contact PI
Facility Core A: Integrative Health Sciences$341,037
P30 · FY2009 · ES · contact PI
Facility Core A: Integrative Health Sciences$336,841
P30 · FY2008 · ES · contact PI
Facility Core A: Integrative Health Sciences$285,193
P30 · FY2007 · ES · contact PI
Molecular Epidemiology of t-MDS/AML$72,825
R03 · FY2007 · CA · contact PI
Molecular Epidemiology of t-MDS/AML$75,000
R03 · FY2006 · CA · contact PI
PROSTATE CANCER IN MEXICANS AMERICANS &AFRICAN AMERICAN$433,530
R01 · FY2003 · CA
PROSTATE CANCER IN MEXICANS AMERICANS &AFRICAN AMERICAN$27,561
R01 · FY2003 · CA
PROSTATE CANCER IN MEXICANS AMERICANS &AFRICAN AMERICAN$496,625
R01 · FY2002 · CA
PROSTATE CANCER: EPIDEMOLOGIC AND CLINICAL MARKERS$291,807
P50 · FY2002 · CA
PROSTATE CANCER IN MEXICANS AMERICANS &AFRICAN AMERICAN$85,697
R01 · FY2002 · CA
Molecular Epidemiology of Myelodysplastic Syndromes$75,000
R03 · FY2002 · CA
Determinants of head and neck cancer$0
U54 · FY2002 · CA
PROSTATE CANCER IN MEXICANS AMERICANS &AFRICAN AMERICAN$467,204
R01 · FY2001 · CA
PROSTATE CANCER IN MEXICANS AMERICANS &AFRICAN AMERICAN$85,437
R01 · FY2001 · CA
BETA 2 ADRENERGIC RECEPTORS AND PROSTATE CANCER RISK$75,500
R03 · FY2001 · CA
Molecular Epidemiology of Myelodysplastic Syndromes$75,000
R03 · FY2001 · CA
PROSTATE CANCER IN MEXICANS AMERICANS &AFRICAN AMERICAN$57,791
R01 · FY2001 · CA
PROSTATE CANCER: EPIDEMOLOGIC AND CLINICAL MARKERS$0
P50 · FY2001 · CA
PROSTATE CANCER IN MEXICANS AMERICANS &AFRICAN AMERICAN$458,351
R01 · FY2000 · CA